The American College of Radiology's (ACR) Image Metrix imaging contract research organization has launched a biomarker and imaging development program.
After partnering with radiopharmacies to address the logistics of using radiolabeled tracers as biomarkers in clinical research, ACR Image Metrix has formed a biomarker imaging development program that includes clinical strategy, trial design, and execution, according to the organization.
General manager Michael Morales said that ACR Image Metrix is currently assisting several sponsors with their biomarker clinical development programs in multiple therapeutic categories.
